Age-dependent decline of β cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study
Research output: Contribution to journal › Journal article › Research › peer-review
C-peptide secretion is currently the only available clinical biomarker to measure residual β-cell function in type 1 diabetes. However, the natural history of C-peptide decline after diagnosis can vary considerably dependent upon several variables. We investigated the shape of C-peptide decline over time from type 1 diabetes onset in relation to age at diagnosis, HbA1c levels and insulin dose.
Original language | English |
---|---|
Journal | Diabetes, Obesity and Metabolism Online |
Volume | 16 |
Issue number | 3 |
Pages (from-to) | 262-267 |
Number of pages | 6 |
ISSN | 1463-1326 |
DOIs | |
Publication status | Published - 1 Oct 2013 |
ID: 96513521